Within Range: Demystifying Diabetes Tech Blog for Healthcare Providers
The development and implementation of Automated Insulin Delivery (AID) systems have significantly advanced the management of type 1 diabetes. Among these systems, Omnipod 5 stands out for its tubeless design, customisable glucose targets, and SmartAdjustTM technology, which provides automated
Every week, clinicians field the same questions from people considering pump therapy: “how will a tubeless insulin pump work in my daily life?”, “what training will I need?”, “how quickly can I get started?”. Explaining the answers in-clinic takes precious time and often leaves patients wanting
Real-World Data Supports Omnipod 5 Automated Insulin Delivery System for Improved Glycaemic Outcomes1
Evidence from the 2023 real-world study by Marks BE, et al. highlights the significant impact the Omnipod 5 Automated
Categories
The Omnipod 5 Automated Insulin Delivery (AID) System is a transformative step in diabetes care. The system merges the benefits and simplicity of a wearable, tubeless design with AID technology.
Managing type 1 diabetes has never been more innovative and personalised, thanks to advancements in automated insulin delivery (AID) systems.
When making treatment decisions for type 1 diabetes (T1D), healthcare professionals increasingly rely on real-world data to understand how therapies perform outside of clinical trials. A recent study— Aleppo G et al. Diabetes Ther. 2023.
Helping people with type 1 diabetes (T1D) stay active has long been a balancing act. Exercise can improve metabolic health and quality of life but also increases the risk of glycaemic variability and hypoglycaemia.1,2